AI is rapidly accelerating scientific discovery and contributing to the effort to better understand cancer. We're proud to announce two major open-source breakthroughs from @GoogleResearch and @GoogleDeepMind that demonstrate the immense potential of AI in this field: First, DeepSomatic can significantly improve cancer diagnostics by accurately identifying key genetic variants within cancer cells, outperforming current state-of-the-art methods. This provides researchers and clinicians with a more precise and reliable tool for mapping cancer's blueprint, which is essential for targeted therapy development. Second, our new Gemma C2S-Scale 27B model (built using our open Gemma family), achieved an exciting milestone: it generated a novel hypothesis to convert "cold" tumors—which are notoriously resistant to current immunotherapies—into "hot" tumors that can be successfully treated. This discovery may offer a new avenue for cancer drug development.